NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only

NSABP Foundation, Inc.

General NSABP Information
  Financial Conflicts of
     Interest Policy
  Contact the NSABP

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-51
  Protocol B-52
  Protocol B-53/S1207
  Protocol B-55/BIG 6-13

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR

To report problems, ask
questions or make comments,
please send e-mail to:

NSABP Clinical Trials Overview

Protocol C-07
A Clinical Trial Comparing 5-Fluorouracil (5-FU) Plus Leucovorin (LV) And Oxaliplatin With 5-FU Plus LV For The Treatment Of Patients With Stages II And III Carcinoma Of The Colon

Specific Aims
The primary aim of this study is to compare the relative efficacy of 5-FU + LV + Oxaliplatin (FLOX) with that of 5-FU + LV (FL) in prolonging Disease Free Survival. The secondary aim of the study is to compare the relative efficacy of FLOX with that of FL in prolonging Survival.